These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15773336)

  • 1. [Gene therapy for Alzheimer' s disease].
    Iwata N; Ozawa K; Saido TC
    Nihon Rinsho; 2005 Mar; 63(3):394-400. PubMed ID: 15773336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of amyloid-beta peptide and Alzheimer's disease.
    Iwata N; Higuchi M; Saido TC
    Pharmacol Ther; 2005 Nov; 108(2):129-48. PubMed ID: 16112736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo.
    Hong CS; Goins WF; Goss JR; Burton EA; Glorioso JC
    Gene Ther; 2006 Jul; 13(14):1068-79. PubMed ID: 16541122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic regulation of brain Abeta by neprilysin.
    Iwata N; Tsubuki S; Takaki Y; Shirotani K; Lu B; Gerard NP; Gerard C; Hama E; Lee HJ; Saido TC
    Science; 2001 May; 292(5521):1550-2. PubMed ID: 11375493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aβ-degrading enzymes: potential for treatment of Alzheimer disease.
    Miners JS; Barua N; Kehoe PG; Gill S; Love S
    J Neuropathol Exp Neurol; 2011 Nov; 70(11):944-59. PubMed ID: 22002425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease.
    Hemming ML; Patterson M; Reske-Nielsen C; Lin L; Isacson O; Selkoe DJ
    PLoS Med; 2007 Aug; 4(8):e262. PubMed ID: 17760499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neprilysin gene transfer: A promising therapeutic approach for Alzheimer's disease.
    Li Y; Wang J; Zhang S; Liu Z
    J Neurosci Res; 2015 Sep; 93(9):1325-9. PubMed ID: 26096375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
    Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
    J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain.
    Iwata N; Mizukami H; Shirotani K; Takaki Y; Muramatsu S; Lu B; Gerard NP; Gerard C; Ozawa K; Saido TC
    J Neurosci; 2004 Jan; 24(4):991-8. PubMed ID: 14749444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice.
    Spencer B; Marr RA; Rockenstein E; Crews L; Adame A; Potkar R; Patrick C; Gage FH; Verma IM; Masliah E
    BMC Neurosci; 2008 Nov; 9():109. PubMed ID: 19014502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amyloid-beta peptide metabolism and Alzheimer's disease].
    Iwata N; Saido TC
    Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):5-14. PubMed ID: 12843567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease.
    Mohajeri MH; Kuehnle K; Li H; Poirier R; Tracy J; Nitsch RM
    FEBS Lett; 2004 Mar; 562(1-3):16-21. PubMed ID: 15043995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease.
    Guan H; Liu Y; Daily A; Police S; Kim MH; Oddo S; LaFerla FM; Pauly JR; Murphy MP; Hersh LB
    J Neurosci Res; 2009 May; 87(6):1462-73. PubMed ID: 19021293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.
    Marr RA; Rockenstein E; Mukherjee A; Kindy MS; Hersh LB; Gage FH; Verma IM; Masliah E
    J Neurosci; 2003 Mar; 23(6):1992-6. PubMed ID: 12657655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neprilysin regulates amyloid Beta peptide levels.
    Marr RA; Guan H; Rockenstein E; Kindy M; Gage FH; Verma I; Masliah E; Hersh LB
    J Mol Neurosci; 2004; 22(1-2):5-11. PubMed ID: 14742905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains.
    Liu Y; Hua Q; Lei H; Li P
    J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal neprilysin overexpression is associated with attenuation of Abeta-related spatial memory deficit.
    Poirier R; Wolfer DP; Welzl H; Tracy J; Galsworthy MJ; Nitsch RM; Mohajeri MH
    Neurobiol Dis; 2006 Dec; 24(3):475-83. PubMed ID: 17008108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient processing of Alzheimer's disease amyloid-Beta peptides by neuroectodermally converted mesenchymal stem cells.
    Habisch HJ; Schmid B; von Arnim CA; Ludolph AC; Brenner R; Storch A
    Stem Cells Dev; 2010 May; 19(5):629-33. PubMed ID: 19469700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice.
    Iwata N; Sekiguchi M; Hattori Y; Takahashi A; Asai M; Ji B; Higuchi M; Staufenbiel M; Muramatsu S; Saido TC
    Sci Rep; 2013; 3():1472. PubMed ID: 23503602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NEP-like endopeptidases and Alzheimer's disease [corrected].
    Marr RA; Spencer BJ
    Curr Alzheimer Res; 2010 May; 7(3):223-9. PubMed ID: 20088804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.